Cantor Fitzgerald Reiterates Overweight on CVS Health, Maintains $87 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on CVS Health (NYSE:CVS) and maintained an $87 price target.
February 08, 2024 | 5:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirmed an Overweight rating on CVS Health, with a price target of $87.
The reaffirmation of an Overweight rating and a specific price target by a reputable analyst like Sarah James could instill confidence among investors, potentially driving short-term positive sentiment towards CVS Health's stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100